390 related articles for article (PubMed ID: 34546371)
61. Management of Clinical T1N0M0 Esophageal Cancer.
Yang AJ; Choi SH; Byun HK; Kim HJ; Choi J; Lee YC; Lee SK; Park KR; Lee CG
Gut Liver; 2019 May; 13(3):315-324. PubMed ID: 30600672
[TBL] [Abstract][Full Text] [Related]
62. Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study.
Semenkovich TR; Subramanian M; Yan Y; Hofstetter WL; Correa AM; Cassivi SD; Inra ML; Stiles BM; Altorki NK; Chang AC; Brescia AA; Darling GE; Allison F; Broderick SR; Etchill EW; Fernandez FG; Chihara RK; Litle VR; Muñoz-Largacha JA; Kozower BD; Puri V; Meyers BF
Ann Thorac Surg; 2019 Sep; 108(3):828-836. PubMed ID: 31229485
[TBL] [Abstract][Full Text] [Related]
63. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
[TBL] [Abstract][Full Text] [Related]
64. Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.
Erhunmwunsee L; Englum BR; Onaitis MW; D'Amico TA; Berry MF
Ann Surg Oncol; 2015 Mar; 22(3):1020-5. PubMed ID: 25234017
[TBL] [Abstract][Full Text] [Related]
65. University hospital status and surgeon volume and risk of reoperation following surgery for esophageal cancer.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Eur J Surg Oncol; 2018 May; 44(5):632-637. PubMed ID: 29548804
[TBL] [Abstract][Full Text] [Related]
66. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
[TBL] [Abstract][Full Text] [Related]
67. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.
Simunovic M; Rempel E; Thériault ME; Coates A; Whelan T; Holowaty E; Langer B; Levine M
Can J Surg; 2006 Aug; 49(4):251-8. PubMed ID: 16948883
[TBL] [Abstract][Full Text] [Related]
68. Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
Salem AI; Thau MR; Strom TJ; Abbott AM; Saeed N; Almhanna K; Hoffe SE; Shridhar R; Karl RC; Meredith KL
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27149640
[TBL] [Abstract][Full Text] [Related]
69. No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base.
Al-Sukhni E; Gabriel E; Attwood K; Kukar M; Nurkin SJ; Hochwald SN
J Am Coll Surg; 2016 Dec; 223(6):784-792.e1. PubMed ID: 27641320
[TBL] [Abstract][Full Text] [Related]
70. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
[TBL] [Abstract][Full Text] [Related]
71. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.
Koëter M; van der Sangen MJ; Hurkmans CW; Luyer MD; Rutten HJ; Nieuwenhuijzen GA
Radiat Oncol; 2015 Mar; 10():59. PubMed ID: 25884226
[TBL] [Abstract][Full Text] [Related]
72. Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis.
Wang S; Huang Y; Xie J; Zhuge L; Shao L; Xiang J; Zhang Y; Sun Y; Hu H; Chen S; Lerut T; Luketich JD; Zhang J; Chen H
Surg Endosc; 2018 Mar; 32(3):1441-1448. PubMed ID: 28916920
[TBL] [Abstract][Full Text] [Related]
73. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
74. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.
Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682
[TBL] [Abstract][Full Text] [Related]
75. Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer.
Visser E; Leeftink AG; van Rossum PS; Siesling S; van Hillegersberg R; Ruurda JP
Ann Surg Oncol; 2016 Aug; 23(8):2679-89. PubMed ID: 27012988
[TBL] [Abstract][Full Text] [Related]
76. High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study.
Hurmuzlu M; Øvrebø K; Monge OR; Smaaland R; Wentzel-Larsen T; Viste A
World J Surg Oncol; 2010 Jun; 8():46. PubMed ID: 20515502
[TBL] [Abstract][Full Text] [Related]
77. Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes.
Spierings LE; Lagarde SM; van Oijen MG; Gisbertz SS; Wilmink JW; Hulshof MC; Meijer SL; Anderegg MC; van Berge Henegouwen MI; van Laarhoven HW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S766-71. PubMed ID: 26350367
[TBL] [Abstract][Full Text] [Related]
78. [Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].
Müller AK; Lenschow C; Palmes D; Senninger N; Hummel R; Lindner K
Chirurg; 2015 Sep; 86(9):874-80. PubMed ID: 25662991
[TBL] [Abstract][Full Text] [Related]
79. Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients.
Jung HK; Tae CH; Lee HA; Lee H; Don Choi K; Park JC; Kwon JG; Choi YJ; Hong SJ; Sung J; Chung WC; Kim KB; Kim SY; Song KH; Park KS; Jeon SW; Kim BW; Ryu HS; Lee OJ; Baik GH; Kim YS; Jung HY;
PLoS One; 2020; 15(4):e0231456. PubMed ID: 32275699
[TBL] [Abstract][Full Text] [Related]
80. Outcomes of T1b esophageal adenocarcinoma patients.
Tian J; Prasad GA; Lutzke LS; Lewis JT; Wang KK
Gastrointest Endosc; 2011 Dec; 74(6):1201-6. PubMed ID: 22000793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]